Oral hairy leukoplakia occurs on the lateral surface of the tongue that clinically as an asymptomatic white lesion. It is mainly found in patient with human immunodeficiency virus infection. However, it rarely outbreak immunosuppressed patients after organ transplantation, or the patients taking steroids or immunosuppressants. It is the result of proliferating Epstein-Barr virus in the oral epithelium. Most of human immunodeficiency virus infected patients with oral hairy leukoplakia are highly contagious and possible to progress acquired immunodeficiency syndrome. Therefore, the early diagnosis of oral hairy leukoplakia is very important. Taking a thorough history and human immunodeficiency virus screening test is highly recommended in case oral hairy leukoplakia is detected. In this case, a 29-year-old man presented with whitish lesion on lateral border of tongue is diagnosed as oral hairy leukoplakia and human immunodeficiency virus infection.
INTRODUCTION
Oral hairy leukoplakia (OHL) typically occurs on the lateral surface of the tongue as a painless whitish plaque that is not removable by rubbing. OHL is known to be caused by Epstein-Barr virus (EBV; human herpesvirus-4) infection. [1] [2] [3] It is mainly found in patients infected with human immunodeficiency virus (HIV). 4) In this case, a 29-year-old man with a lesion on the lateral borders of the tongue was screened and diagnosed with HIV infection.
CASE REPORT
A 29-year-old man presented with whitish lesion of tongue. The lesion developed 4 months ago. He had no history of systemic disease and had not taken any medication.
He was healthy and a nonsmoker.
Clinical examination revealed whitish plaque with co rru gated and hairy surface on the lateral border of tongue ( (Table 1) . [9] [10] [11] [12] Treatment is seldom required since OHL is usually symptomless and self-limiting. There are few studies about the treatments for OHL. 5, [13] [14] [15] It was reported that combination therapy of 25% podophyllin and 5% acyclovir cream is the most effective method to manage OHL. 
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